Literature DB >> 20117169

ZAC1 target genes and pituitary tumorigenesis.

Marily Theodoropoulou1, Günter K Stalla, Dietmar Spengler.   

Abstract

The zinc-finger protein Zac1 has a role as transcription factor and coregulator and plays an important role in pituitary development, maturation and tumorigenesis. Zac1 target genes control cell proliferation and hormone synthesis. While Zac1 is highly expressed in all hormone-producing cells of the pituitary, loss of expression frequently occurs in pituitary adenomas, in particular in non-functioning tumors. Zac1 lies downstream to the mitogenic MAPK and survival PI3K pathways. In turn, inhibition of the PI3K pathway by therapeutic agents, like somatostatin analogs up-regulate Zac1 expression. In fact Zac1 is an essential mediator of the antiproliferative effects of this treatment and correlates to successful outcome in acromegalic patients. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117169     DOI: 10.1016/j.mce.2010.01.033

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  22 in total

1.  Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors.

Authors:  Katherine A Michaelis; Aaron J Knox; Mei Xu; Katja Kiseljak-Vassiliades; Michael G Edwards; Mark Geraci; B K Kleinschmidt-DeMasters; Kevin O Lillehei; Margaret E Wierman
Journal:  Endocrinology       Date:  2011-08-02       Impact factor: 4.736

Review 2.  Imprinted Zac1 in neural stem cells.

Authors:  Guillaume Daniel; Udo Schmidt-Edelkraut; Dietmar Spengler; Anke Hoffmann
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 3.  Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance.

Authors:  Rosa Maria Paragliola; Salvatore Maria Corsello; Roberto Salvatori
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 4.  Somatostatin receptor ligands in the treatment of acromegaly.

Authors:  Monica R Gadelha; Luiz Eduardo Wildemberg; Marcello D Bronstein; Federico Gatto; Diego Ferone
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

5.  Pituitary gland: New pathways in the pathogenesis of pituitary adenomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Nat Rev Endocrinol       Date:  2012-08-07       Impact factor: 43.330

Review 6.  PLAGL1: an important player in diverse pathological processes.

Authors:  Ana F Vega-Benedetti; Cinthia Saucedo; Patrizia Zavattari; Roberta Vanni; José L Zugaza; Luis Antonio Parada
Journal:  J Appl Genet       Date:  2016-06-16       Impact factor: 3.240

Review 7.  Familial isolated pituitary adenomas: from genetics to therapy.

Authors:  Federica Guaraldi; Roberto Salvatori
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

8.  Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors.

Authors:  Katja Kiseljak-Vassiliades; Mei Xu; Taylor S Mills; Elizabeth E Smith; Lori J Silveira; Kevin O Lillehei; Janice M Kerr; B K Kleinschmidt-DeMasters; Margaret E Wierman
Journal:  Mol Cell Endocrinol       Date:  2015-09-21       Impact factor: 4.102

Review 9.  Importance of the matriline for genomic imprinting, brain development and behaviour.

Authors:  E B Keverne
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

Review 10.  PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas.

Authors:  Hadara Rubinfeld; Ilan Shimon
Journal:  Endocrine       Date:  2012-05-03       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.